JK
Jasmine Kaur Basu
About Jasmine Kaur Basu
Data last updated:
Jasmine Kaur Basu is a Director at Jagat Pharma Private Limited (since 2024) and Director at Mirasa International Private Limited (since 2022). The companies operate in Healthcare and Chemicals. The largest current company by reported revenue is Jagat Pharma Private Limited at ₹28.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jagat Pharma Private Limited U24290DL2022PTC403320 | Director | 08 Oct 2024 | 2022 | ₹28.15 Cr (FY 2025) | Active |
| Mirasa International Private Limited U24239DL2022PTC401600 | Director | 12 Jul 2022 | 2022 | Active |
Board colleagues of Jasmine Kaur Basu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahender Singh Basu | 09707859 | Jagat Pharma Private Limited | Director |
| Mandeep Singh Basu | 09670991 | Jagat Pharma Private Limited , Mirasa International Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jasmine Kaur Basu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jasmine Kaur Basu
Jasmine Kaur Basu currently holds 2 directorships: Jagat Pharma Private Limited (Director, since 08 Oct 2024, revenue ₹28.15 Cr (FY 2025)); Mirasa International Private Limited (Director, since 12 Jul 2022).
Jasmine Kaur Basu was first appointed on 12 Jul 2022 as Director at Mirasa International Private Limited. The most recent appointment on record is 08 Oct 2024 at Jagat Pharma Private Limited.
The current boards of Jasmine Kaur Basu's companies include Mahender Singh Basu (Jagat Pharma Private Limited), Mandeep Singh Basu (Jagat Pharma Private Limited).